Sobhani, N., Fassl, A., Mondani, G., Generali, D., & Otto, T. (2021). Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer. Cells.
Style de citation ChicagoSobhani, Navid, Anne Fassl, Giuseppina Mondani, Daniele Generali, et Tobias Otto. "Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer." Cells 2021.
Style de citation MLASobhani, Navid, et al. "Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer." Cells 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.